Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

562
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
562
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

1.0K
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.0K
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

3.1K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.1K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

490
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
490
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

2.1K
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Killip class at presentation and immediate versus staged multivessel PCI in patients with STEMI.

Scientific reports·2026
Same author

Invasive transvalvular flow rate to predict likely severe aortic valve stenosis with low-gradient and normal ejection fraction.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

Impact of the invasively measured flow-gradient pattern on clinical outcomes and ventricular remodeling after transcatheter aortic valve implantation in patients with severe aortic stenosis and preserved ejection fraction.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

Impact of renal dysfunction on immediate versus staged revascularization of non-culprit lesions in patients with ST segment elevation myocardial infarction: a pre-specified subgroup analysis of the randomized MULTISTARS AMI trial.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

In-Hospital and 1-Year Outcomes of Octogenarian and Nonagenarian Patients with Severely Calcified Coronary Lesions Treated with Rotational Atherectomy.

Cardiology and therapy·2026
Same author

Ten-Year Outcomes of Patients with Left Main Coronary Artery Disease and Diabetes Mellitus Treated with Percutaneous Coronary Intervention.

Journal of clinical medicine·2025

Related Experiment Video

Updated: Apr 20, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

732

Update on transcatheter aortic valve replacement.

Mohamed Abdel-Wahab1, Mohamed El-Mawardy1, Gert Richardt1

  • 1Heart Center, Segeberger Kliniken GmbH, Am Kurpark 1, Bad Segeberg 23795, Germany.

Trends in Cardiovascular Medicine
|December 3, 2014
PubMed
Summary

Transcatheter aortic valve replacement (TAVR) offers a mortality benefit for inoperable patients with severe aortic stenosis. It is also non-inferior to surgery in high-risk patients, with ongoing advancements improving outcomes.

More Related Videos

Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
06:59

Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation

Published on: June 3, 2018

11.2K
Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
09:57

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Published on: January 20, 2022

3.3K

Related Experiment Videos

Last Updated: Apr 20, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

732
Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
06:59

Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation

Published on: June 3, 2018

11.2K
Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
09:57

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Published on: January 20, 2022

3.3K

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Technology

Background:

  • Severe aortic stenosis poses significant risks, especially for inoperable or high-risk surgical candidates.
  • Transcatheter aortic valve replacement (TAVR) has emerged as a primary treatment option.
  • TAVR demonstrates improved survival rates compared to conservative management and comparable outcomes to surgical valve replacement in high-risk individuals.

Purpose of the Study:

  • To review the current status and recent advancements in Transcatheter Aortic Valve Replacement (TAVR).
  • To discuss the future trajectory of TAVR technology and its clinical applications.

Main Methods:

  • This review synthesizes current literature and clinical data on TAVR.
  • It examines improvements in imaging, valve technology, and procedural experience.
  • Expert insights and research trends are considered.

Main Results:

  • TAVR provides a significant mortality benefit for inoperable patients with severe aortic stenosis.
  • In high-risk operable patients, TAVR is at least non-inferior to surgical aortic valve replacement.
  • Continuous technological and procedural refinements are enhancing TAVR efficacy and safety.

Conclusions:

  • Transcatheter aortic valve replacement is a well-established and rapidly evolving treatment for severe aortic stenosis.
  • Ongoing research and technological innovation are expected to further expand TAVR's role in cardiovascular care.
  • The future of TAVR appears promising, with potential for broader application and improved patient outcomes.